Neuroblastoma in advanced stages is among the most intractable pediatric cancers, even with the recent therapeutic advances. Neruroblastoma harbours a variety of genetic changes, including a high freq
FPC grading scores (0–3) are shown for each phenotypic group. Footnote: Age ranges between phenotypic groups are not significantly different within and between A and B genecard groups (Wilcoxon test p
